These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3035912)

  • 1. cis-platinum, 5-fluorouracil, and hydroxyurea in the treatment of advanced non-small-cell lung cancer. A phase II study.
    Axelson JA; Clark RH; Dimitrov NV
    Am J Clin Oncol; 1987 Jun; 10(3):243-4. PubMed ID: 3035912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair. A phase II study in non-small-cell lung cancer.
    Cantwell BM; Veale D; Rivett C; Ghani S; Harris AL
    Cancer Chemother Pharmacol; 1989; 23(4):252-4. PubMed ID: 2538251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).
    Kentepozidis N; Economopoulou P; Christofyllakis C; Chelis L; Polyzos A; Vardakis N; Koinis F; Vamvakas L; Katsaounis P; Kalbakis K; Nikolaou C; Georgoulias V; Kotsakis A
    Clin Transl Oncol; 2017 Mar; 19(3):317-325. PubMed ID: 27492015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
    Nakano T; Ikegami H; Nakamura S; Kawase T; Nishikawa H; Yokota S; Yoshida M; Tachibana T; Igarashi T; Komuta K; Higashino K
    Br J Cancer; 1996 May; 73(9):1096-100. PubMed ID: 8624270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group.
    Weiden PL; Piantadosi S
    J Natl Cancer Inst; 1991 Feb; 83(4):266-73. PubMed ID: 1847220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
    Vokes EE; Moormeier JA; Ratain MJ; Egorin MJ; Haraf DJ; Mick R; Weichselbaum RR
    Cancer Chemother Pharmacol; 1992; 29(3):178-84. PubMed ID: 1733549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin bolus and 5-FU infusion chemotherapy for non-small cell lung cancer.
    Weiden PL; Einstein AB; Rudolph RH
    Cancer Treat Rep; 1985 Nov; 69(11):1253-5. PubMed ID: 4092189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
    Fujita A; Sasaki H; Mori T; Nakajima S; Sekine K; Inoue Y; Honda R; Asakawa M; Suzuki A
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):51-5. PubMed ID: 1846283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer.
    Ellis PA; Talbot DC; Nicolson MC; Priest K; Ashley S; Smith IE
    Br J Cancer; 1995 Jun; 71(6):1315-8. PubMed ID: 7779730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
    Ohnoshi T; Hiraki S; Ueoka H; Tamura T; Kawahara S; Yonei T; Yamashita H; Ishii J; Tamai M; Egawa T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer.
    Sandler A; Graham C; Baggstrom M; Herbst R; Zergebel C; Saito K; Jones D
    J Thorac Oncol; 2011 Aug; 6(8):1400-6. PubMed ID: 21673602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant chemoradiotherapy for non-small cell lung cancer.
    Vokes EE; Haraf DJ; Hoffman PC; Bitran JD; Ferguson MK; Golomb HM
    Lung Cancer; 1994 Mar; 10 Suppl 1():S253-61. PubMed ID: 8087518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer.
    O'Dwyer PJ; Langer CJ; Walczak J; Levy MH; Padavic-Shaller K; Hudes GR; Litwin S; Comis RL
    Eur J Cancer; 1991; 27(12):1589-93. PubMed ID: 1664216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.